Prescribing, clinical practice and regulatory change for the clinicians building this field.
Researchers in Scotland are testing CBD for endometriosis and the lasting effects of chemotherapy, while European back-pain trials have helped bring a cannabis medicine to market. Cannabis Health looks at the studies, their findings and what comes next.
Families of patients with treatment-resistant epilepsy in the UK have received confirmation from a UK drug manufacturer that a six-month supply of Bedrolite is available. In an email sent to […]
Could cannabinoids offer an alternative to opioids for people living with chronic pain – and what does the evidence actually show?
What have Germany’s cannabis reforms meant for drug use, public health, young people and the black market?
Cannabis may help some people with ADHD manage symptoms such as restlessness and impulsivity – but research suggests it could make other symptoms worse.
Medical cannabis has been legal on prescription in Northern Ireland since 1 November 2018.
Interest in medical cannabis for autism is growing among patients, families and clinicians, but research has yet to establish whether it is an effective treatment.
In the eight years since, the NHS has issued just five prescriptions for unlicenced specials cannabis medicines, creating a two-tier system with access only to those who can afford to pay for it.
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use.’
The study is evaluating MRX1, the company’s proprietary CBD-based oral solution, as a treatment for chemotherapy-induced peripheral neuropathy (CIPN).
Pharmacist independent prescribers accounted for 61.9% of the total items prescribed between January 2019 and May 2025.
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Directory
Browse verified UK medical cannabis clinics and pharmacies — online and in person.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
